,Variant_classification,Gene_classification,Comment,Difficultregion,CNV-SNV,ID,OMIM_Phenotype,Disease,Clinical_synopsis,OMIM_Link,Uniprot,Inheritance,Zygosity,CHR,POS,REF,ALT,Flank,Repeat_flag,FILTER,FORMAT,VAF,Pileup_data,Mutation_type,Gene_name,Entrez_Gene_Id,In_Key_Gene,HGVS_nomenclature,HGMD_transcript,ExonNumber,PolarChange,1000G_ASN_AF,1000G_ALL_AF,ESP6500_AC,ESP6500_AF,gnomAD_exome_ALL,gnomAD_exome_EAS,gnomAD_genome_ALL,gnomAD_genome_EAS,ExAC_EAS_HomoAlt_Count,ExAC_EAS_AC,ExAC_EAS_AF,ExAC_HomoAlt_Count,ExAC_AC,ExAC_AF,In_house_freq,In_house_count,ExAC_Link,ExAC_MisZ,ExAC_Expected,ExAC_observed,ExAC_PLI,PLI_Link,Phylop_Vertebrate_score,Phylop_Mammal_score,SIFT_score,SIFT_prediction,Polyphen2_HDIV_score,Polyphen2_HDIV_pred,Polyphen2_HVAR_score,Polyphen2_HVAR_pred,LRT_score,LRT_prediction,Mutationtatser_score,Mutationtatser_prediction,Gerp++,CADD,Rs_ID,Swiss_prot_function,Swiss_prot_disease_association,Swiss_prot_post_translational_modifications,Swiss_prot_expression,HGMD_mutation_type,HGMD_variant_class,HGMD_disease,HGMD_pubmed_ID,HGMD_indel_type,HGMD_Indel_class,HGMD_indel_disease,HGMD_indel_PMID,HGMD_nearby_alleles,Clinvar,Clinvar_Link,CosmicID,Cosmic_Occurence,Mother_zygosity,Mother_filter,Mother_format,Mother_VAF,Mother_pileup,Father_zygosity,Father_filter,Father_format,Father_VAF,Father_pileup,Recessive,Com_het,De_novo,Other_relatives,Covered,Less_20,GO_BP,GO_CC,GO_MF,KEGG_PATHWAY,PID_PATHWAY,BIOCARTA_PATHWAY,REACTOME_PATHWAY,pheno_rank,intersect_rank,CaseID
271,.,.,HGMD|OMIM,"Name=mappability,SegmentalDuplications",.,WAX032,613642;256000;252011;614165,"Cardiomyopathy, dilated, 1GG;Leigh syndrome;Mitochondrial respiratory chain complex II deficiency;Paragangliomas 5","1.$$$mimNumber,256000###prefix,####preferredTitle,LEIGH SYNDROME; LS###inheritance,Autosomal recessive ;###inheritance,Mitochondrial ###growthOther,Failure to thrive ###headAndNeckEyes,Ophthalmoplegia ;###headAndNeckEyes,Optic atrophy ;###headAndNeckEyes,Nystagmus ;###headAndNeckEyes,Strabismus ;###headAndNeckEyes,Ptosis ;###headAndNeckEyes,Pigmentary retinopathy ###respiratory,Abnormal respiratory patterns ;###respiratory,Respiratory failure ###skinNailsHairHair,Hypertrichosis ###muscleSoftTissue,Hypotonia ###neurologicCentralNervousSystem,Psychomotor retardation ;###neurologicCentralNervousSystem,Hypotonia ;###neurologicCentralNervousSystem,Ataxia ;###neurologicCentralNervousSystem,Dystonia ;###neurologicCentralNervousSystem,Dysarthria ;###neurologicCentralNervousSystem,Spasticity ;###neurologicCentralNervousSystem,Hyperreflexia ;###neurologicCentralNervousSystem,Seizures ;###neurologicCentralNervousSystem,Brainstem abnormalities ;###neurologicCentralNervousSystem,Mental retardation ;###neurologicCentralNervousSystem,Lesions in basal ganglia, brainstem, cerebellum, thalamus, spinal cord characterized by demyelination, necrosis, gliosis, spongiosis, and capillary proliferation ###neurologicBehavioralPsychiatricManifestations,Emotional lability ###metabolicFeatures,Lactic acidosis ###laboratoryAbnormalities,Increased serum lactate ;###laboratoryAbnormalities,Increased CSF lactate ###miscellaneous,Onset usually in infancy or early childhood ;###miscellaneous,Progressive disorder, usually with rapid, relentless course ;###miscellaneous,Clinical heterogeneity ;###miscellaneous,Genetic heterogeneity (may be caused by mutation in nuclear-encoded or mitochondrial-encoded genes) ;###miscellaneous,Subset of patients have cytochrome c oxidase deficiency (see );###miscellaneous,See also X-linked Leigh syndrome ();###miscellaneous,See also French-Canadian type of Leigh syndrome ()###molecularBasis,Caused by mutation in the NADH dehydrogenase, subunit 2 gene (MTND2, );###molecularBasis,Caused by mutation in the NADH dehydrogenase, subunit 3 gene (MTND3, );###molecularBasis,Caused by mutation in the NADH dehydrogenase, subunit 5 gene (MTND5, );###molecularBasis,Caused by mutation in the NADH dehydrogenase, subunit 6 gene (MTND6, );###molecularBasis,Caused by mutation in the ATP synthase 6 gene (MTATP6, );###molecularBasis,Caused by mutation in the cytochrome c oxidase III gene (MTCO3, );###molecularBasis,Caused by mutation in the mitochondrial tRNA (valine) gene (MTTV, );###molecularBasis,Caused by mutation in the mitochondrial tRNA (lysine) gene (MTTK, );###molecularBasis,Caused by mutation in the NADH-ubiquinone oxidoreductase 1 alpha subcomplex, 2 gene (NDUFA2, );###molecularBasis,Caused by mutation in the NADH-ubiquinone oxidoreductase 1 alpha subcomplex, 10 gene (NDUFA10, );###molecularBasis,Caused by mutation in the NADH-ubiquinone oxidoreductase 1 alpha subcomplex, 12 gene (NDUFA12, );###molecularBasis,Caused by mutation in the NADH dehydrogenase (ubiquinone) complex I, assembly factor 5 gene (NDUFAF5, );###molecularBasis,Caused by mutation in the NADH dehydrogenase (ubiquinone) Fe-S protein 3 gene (NDUFV3, );###molecularBasis,Caused by mutation in the NADH dehydrogenase (ubiquinone) Fe-S protein 1 gene (NDUFS1, );###molecularBasis,Caused by mutation in the NADH dehydrogenase (ubiquinone) Fe-S protein 4 gene (NDUFS4, );###molecularBasis,Caused by mutation in the NADH dehydrogenase (ubiquinone) Fe-S protein 7 gene (NDUFS7, );###molecularBasis,Caused by mutation in the NADH dehydrogenase (ubiquinone) Fe-S protein 8 gene (NDUFS8, );###molecularBasis,Caused by mutation in the NADH-ubiquinone oxidoreductase 1 alpha subcomplex 9 gene (NDUFA9, );###molecularBasis,Caused by mutation in the succinate dehydrogenase complex, subunit A, flavoprotein gene (SDHA, );###molecularBasis,Caused by mutation in the FAD-dependent oxidoreductase domain-containing protein 1 gene (FOXRED1, );###molecularBasis,Caused by mutation in the bcs1, S. cerevisiae, homolog-like gene (BCS1L, );###molecularBasis,Caused by mutation in the surfeit-1 gene (SURF1, );###molecularBasis,Caused by mutation in the cytochrome c oxidase, subunit 15 gene (COX15, );###molecularBasis,Caused by mutation in the C8ORF38 gene (C8ORF38, );###molecularBasis,Caused by mutation in the translational activator of mitochondrially encoded cytochrome c oxidase subunit 1 gene (TACO1, );###molecularBasis,Caused by mutation in the mitochondrial methionyl-tRNA formyltransferase gene (MTFMT, );###molecularBasis,Caused by mutation in the homolog of the S. cerevisiae PET100 gene (PET100, ). 2.$$$mimNumber,252011###prefix,####preferredTitle,MITOCHONDRIAL COMPLEX II DEFICIENCY###inheritance,Autosomal recessive ###growthHeight,Short stature ###growthOther,Poor growth ###headAndNeckEyes,Ptosis ;###headAndNeckEyes,Ophthalmoplegia ;###headAndNeckEyes,Pigmentary retinopathy ;###headAndNeckEyes,Optic atrophy ;###headAndNeckEyes,Nystagmus ;###headAndNeckEyes,Impaired vision ###cardiovascularHeart,Hypertrophic cardiomyopathy ;###cardiovascularHeart,Dilated cardiomyopathy ;###cardiovascularHeart,Left ventricular noncompaction ###skeletal,Joint contractures ###muscleSoftTissue,Hypotonia, neonatal ;###muscleSoftTissue,Muscle weakness ;###muscleSoftTissue,Exercise intolerance ;###muscleSoftTissue,Ragged red fibers seen on muscle biopsy ;###muscleSoftTissue,Abnormal mitochondria with paracrystalline inclusions seen on muscle biopsy ;###muscleSoftTissue,Accumulated lipid droplets seen on muscle biopsy ###neurologicCentralNervousSystem,Psychomotor regression in infants ;###neurologicCentralNervousSystem,Spasticity ;###neurologicCentralNervousSystem,Hyperreflexia ;###neurologicCentralNervousSystem,Extensor plantar responses ;###neurologicCentralNervousSystem,Ataxia ;###neurologicCentralNervousSystem,Cognitive impairment ;###neurologicCentralNervousSystem,Dystonia ;###neurologicCentralNervousSystem,Myoclonus ;###neurologicCentralNervousSystem,Seizures ;###neurologicCentralNervousSystem,Leukoencephalopathy, progressive ;###neurologicCentralNervousSystem,Spongiform encephalomyelopathy ;###neurologicCentralNervousSystem,Leigh syndrome (), in a subset of patients;###neurologicCentralNervousSystem,Kearns-Sayre syndrome (), in a subset of patients###metabolicFeatures,Lactic acidosis may occur with stress or infection ###laboratoryAbnormalities,Decreased activity of mitochondrial complex II (succinate dehydrogenase) ;###laboratoryAbnormalities,Mildly increased serum lactate ###miscellaneous,Onset in first year of life ;###miscellaneous,Highly variable phenotype ###molecularBasis,Caused by mutation in the flavoprotein subunit of succinate dehydrogenase complex gene (SDHA, );###molecularBasis,Caused by mutation in the succinate dehydrogenase complex assembly factor 1 gene (SDHAF1, );###molecularBasis,Caused by mutation in the succinate dehydrogenase complex, subunit D, integral membrane protein gene (SDHD, ) 3.$$$mimNumber,614165###prefix,####preferredTitle,PARAGANGLIOMAS 5; PGL5###inheritance,Autosomal dominant ###neoplasia,Paraganglioma ###miscellaneous,Variable locations ###molecularBasis,Caused by mutation in the succinate dehydrogenase complex, subunit A, flavoprotein gene (SDHA, )",https://www.omim.org/entry/613642;https://www.omim.org/entry/256000;https://www.omim.org/entry/252011;https://www.omim.org/entry/614165,.,"Autosomal recessive, Mitochondrial;Autosomal recessive;Autosomal dominant",Het,5,224487,T,C,.,.,PASS,0/1:18:46,39.13,",..C.CC..,C,.Cc,c,CCA..,c,,Cc,C..c.CC,,,,.C,",missense_variant,SDHA,6389,.,NM_004168.2(SDHA):c.163T>C(p.Tyr55His),NM_004168.3,exon3(15),P0=>P+,0.016,0.0032,0,0,0.0015,0.0197,0.0009,0.0173,2,172,0.020,3,185,0.0015,0.0389344262295,19/488,http://exac.broadinstitute.org/variant/5-224487-T-C,2.32,27.7,13,0.0,http://exac.broadinstitute.org/gene/ENSG00000073578,0.63513,.,0,D,0.512,P,0.308,B,0.000,U,1.000,D,5.35,17.74,rs142926807,.,.,.,.,.,.,.,.,.,.,.,.,"NM_004168.3(SDHA):c.160C>T(p.Q54*),DM,Gastrointestinal tumour, stromal,22974104",.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,cellular metabolic process (GO:0044237)|nervous system development (GO:0007399)|oxidation-reduction process (GO:0055114)|respiratory electron transport chain (GO:0022904)|small molecule metabolic process (GO:0044281)|succinate metabolic process (GO:0006105)|tricarboxylic acid cycle (GO:0006099),mitochondrial inner membrane (GO:0005743)|mitochondrial respiratory chain complex II (GO:0005749)|mitochondrion (GO:0005739),flavin adenine dinucleotide binding (GO:0050660)|succinate dehydrogenase (ubiquinone) activity (GO:0008177),.,.,.,.,12,0,WAX032
450,.,.,HGMD|OMIM,.,.,WAX032,133701;616682,"Exostoses, multiple, type 2;?Seizures, scoliosis, and macrocephaly syndrome","1.$$$mimNumber,133701###prefix,####preferredTitle,EXOSTOSES, MULTIPLE, TYPE II###inheritance,Autosomal dominant ###growthHeight,Short stature in less than 50% ###chestRibsSternumClaviclesAndScapulae,Rib exostoses ;###chestRibsSternumClaviclesAndScapulae,Scapular exostoses ###skeletalPelvis,Coxa vara ;###skeletalPelvis,Pelvic exostoses ###skeletalLimbs,Protuberances at ends of long bones ;###skeletalLimbs,Short metacarpal ;###skeletalLimbs,Exostoses in juxtaepiphyseal regions of the long bones ;###skeletalLimbs,Genu valgum ;###skeletalLimbs,Madelung-like forearm deformities ###neurologicPeripheralNervousSystem,Peripheral nerve compression ;###neurologicPeripheralNervousSystem,Cervical myelopathy ###neoplasia,Increased risk of chondrosarcoma ###miscellaneous,More severe in males than in females ;###miscellaneous,Onset early childhood ;###miscellaneous,Lesions continue to grow until epiphyseal plate closure ###molecularBasis,Caused by mutations in the exostosin 2 gene (EXT2, ) 2.$$$mimNumber,616682###prefix,####preferredTitle,SEIZURES, SCOLIOSIS, AND MACROCEPHALY SYNDROME; SSMS###inheritance,Autosomal recessive ###headAndNeckHead,Macrocephaly ###headAndNeckFace,Coarse facies ;###headAndNeckFace,Long hypoplastic philtrum ###headAndNeckEyes,Hypertelorism ;###headAndNeckEyes,Strabismus ###cardiovascularHeart,Ventricular septal defect (in 2 of 4 patients) ###abdomenGastrointestinal,Gastroesophageal reflux ;###abdomenGastrointestinal,Constipation ;###abdomenGastrointestinal,Bowel malrotation (in 2 of 4 patients) ###genitourinaryInternalGenitaliaMale,Cryptorchidism ###genitourinaryKidneys,Hemolytic-uremic syndrome requiring dialysis (1 patient) ###skeletal,Decreased bone density ###skeletalSpine,Scoliosis ###skeletalFeet,Overlapping toes ###skinNailsHairSkin,Sensitive skin ###muscleSoftTissue,Hypotonia ###neurologicCentralNervousSystem,Delayed psychomotor development ;###neurologicCentralNervousSystem,Poor speech ;###neurologicCentralNervousSystem,Seizures ;###neurologicCentralNervousSystem,Nonspecific background slowing with focal spikes seen on EEG ;###neurologicCentralNervousSystem,Brain hemorrhage (in 2 of 4 patients) ###miscellaneous,Onset in infancy ;###miscellaneous,Onset of seizures between 2 and 5 years ;###miscellaneous,Four sibs from the Old Order Mennonite Community has been reported (last curated December 2015) ###molecularBasis,Caused by mutation in the exostosin glycosyltransferase 2 gene (EXT2, )",https://www.omim.org/entry/133701;https://www.omim.org/entry/616682,.,Autosomal dominant;Autosomal recessive,Het,11,44265893,G,A,.,.,PASS,0/1:38:82,46.34,"a.,,,aaAA,a,a,,.,.,.,.AaA,.aA.A,A,,A.aA.aa,..a.,,AaaA,Aa,aAA,a,a,.Aa.,,,a,",3_prime_UTR_variant;3_prime_UTR_variant;3_prime_UTR_variant,EXT2,2132,.,NM_207122.1(EXT2):c.*56G>A;NM_001178083.1(EXT2):c.*56G>A;NM_000401.3(EXT2):c.*56G>A,NM_207122.1,exon14(14);exon15(15);exon14(14),.;.;.,0.036,0.014,.,.,.,.,0.0041,0.0272,.,.,.,.,.,.,0.0799180327869,39/488,.,0.49,26.8,15,0.0,http://exac.broadinstitute.org/gene/ENSG00000151348,.,.,.,.,.,.,.,.,.,.,.,.,.,.,rs77554103,.,.,.,.,,DM?,Multiple exostoses,17301954,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,"carbohydrate metabolic process (GO:0005975)|cell differentiation (GO:0030154)|cellular polysaccharide biosynthetic process (GO:0033692)|glycosaminoglycan biosynthetic process (GO:0006024)|glycosaminoglycan metabolic process (GO:0030203)|heparan sulfate proteoglycan biosynthetic process (GO:0015012)|heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process (GO:0015014)|mesoderm formation (GO:0001707)|ossification (GO:0001503)|protein glycosylation (GO:0006486)|signal transduction (GO:0007165)|small molecule metabolic process (GO:0044281)",endoplasmic reticulum (GO:0005783)|endoplasmic reticulum membrane (GO:0005789)|extracellular vesicular exosome (GO:0070062)|Golgi apparatus (GO:0005794)|Golgi membrane (GO:0000139)|integral component of membrane (GO:0016021)|intrinsic component of endoplasmic reticulum membrane (GO:0031227)|membrane (GO:0016020),"glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity (GO:0050508)|glucuronosyltransferase activity (GO:0015020)|heparan sulfate N-acetylglucosaminyltransferase activity (GO:0042328)|N-acetylglucosaminyl-proteoglycan 4-beta-glucuronosyltransferase activity (GO:0050509)|protein heterodimerization activity (GO:0046982)|transferase activity, transferring glycosyl groups (GO:0016757)",.,.,.,.,96,3,WAX032
563,.,.,OMIM|low_frequency,.,.,WAX032,616113,?Polyendocrine-polyneuropathy syndrome,"1.$$$mimNumber,616113###prefix,####preferredTitle,POLYENDOCRINE-POLYNEUROPATHY SYNDROME; PEPNS###inheritance,Autosomal recessive ###growthHeight,Short stature ###growthOther,Postnatal growth retardation ###headAndNeckHead,Partial frontal alopecia ###headAndNeckEars,Progressive hearing loss ###headAndNeckNose,Normal sense of smell ###genitourinaryExternalGenitaliaMale,Small testicular volume ###skinNailsHairHair,Partial frontal alopecia ###neurologicCentralNervousSystem,Mental retardation, moderate ;###neurologicCentralNervousSystem,Dysarthria ;###neurologicCentralNervousSystem,Dystonia ;###neurologicCentralNervousSystem,Ataxia ;###neurologicCentralNervousSystem,Pyramidal syndrome ;###neurologicCentralNervousSystem,Subcortical temporal white matter disease, moderate ;###neurologicCentralNervousSystem,Cerebellar hypoplasia, mild (in some patients) ;###neurologicCentralNervousSystem,Hypoplastic pituitary gland (in some patients) ###neurologicPeripheralNervousSystem,Peripheral demyelinating polyneuropathy ;###neurologicPeripheralNervousSystem,Motor delay ###endocrineFeatures,Hypogonadotropic hypogonadism ;###endocrineFeatures,Low testosterone levels ;###endocrineFeatures,Low luteinizing hormone levels ;###endocrineFeatures,Low follicle-stimulating hormone levels ;###endocrineFeatures,Central hypothyroidism ;###endocrineFeatures,Low free-T4 levels ;###endocrineFeatures,Normal thyroid-stimulating hormone level ;###endocrineFeatures,Episodic asymptomatic severe hypoglycemia in childhood ;###endocrineFeatures,Nonautoimmune insulin-dependent diabetes in second decade of life ###miscellaneous,One consanguineous Senegalese family has been reported (last curated December 2014) ###molecularBasis,Caused by mutation in the DMX-like 2 gene (DMXL2, )",https://www.omim.org/entry/616113,.,Autosomal recessive,Het,15,51741221,T,C,.,.,PASS,0/1:64:124,51.61,"c$c$.c.C.CC,,C,,.c,c,..,Cc,.,ccccC.,..,ccc,,,,,cc,,cc,c..c,,C,,cccccC,cCc.,.C,cCc.,,,cCcccc,,.c.C,c,.cc,C.,,cc,,c,cccCC.,,^]C",missense_variant;missense_variant;missense_variant,DMXL2,23312,.,NM_001174116.1(DMXL2):c.9074A>G(p.Asn3025Ser);NM_001174117.1(DMXL2):c.7163A>G(p.Asn2388Ser);NM_015263.3(DMXL2):c.9071A>G(p.Asn3024Ser),NM_001174116.1,exon43(43);exon41(41);exon43(43),P0=>P0;P0=>P0;P0=>P0,.,.,0,0,8.125e-06,5.8e-05,.,.,0,1,0.00012,0,2,0.000017,.,.,http://exac.broadinstitute.org/variant/15-51741221-T-C,0.65,102.1,10,1.0,http://exac.broadinstitute.org/gene/ENSG00000104093,0.35226,.,0.17,T,0.037,B,0.015,B,0.001,N,0.991,N,-5.69,12.63,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,cell junction (GO:0030054)|extracellular space (GO:0005615)|membrane (GO:0016020)|synaptic vesicle (GO:0008021),Rab GTPase binding (GO:0017137),.,.,.,.,60,2,WAX032
671,.,.,OMIM|low_frequency,.,.,WAX032,610549;609968;246200;262190,"Diabetes mellitus, insulin-resistant, with acanthosis nigricans;Hyperinsulinemic hypoglycemia, familial, 5;Leprechaunism;Rabson-Mendenhall syndrome","1.$$$mimNumber,609968###prefix,####preferredTitle,HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 5; HHF5###inheritance,Autosomal dominant ###neurologicCentralNervousSystem,Loss of consciousness due to hypoglycemia ;###neurologicCentralNervousSystem,Seizures, hypoglycemic ###endocrineFeatures,Hyperinsulinemic hypoglycemia ###laboratoryAbnormalities,Hypoglycemia, postprandial ;###laboratoryAbnormalities,Hyperinsulinemia, fasting ;###laboratoryAbnormalities,Elevated serum insulin-to-C-peptide ratio ###miscellaneous,Genetic heterogeneity (see HHF1 ###molecularBasis,Caused by mutation in the insulin receptor gene (INSR, ) 2.$$$mimNumber,246200###prefix,####preferredTitle,DONOHUE SYNDROME###inheritance,Autosomal recessive ###growthOther,Prenatal growth retardation ;###growthOther,Postnatal growth retardation ;###growthOther,Severe failure to thrive ###headAndNeckFace,Elfin facies ;###headAndNeckFace,Small face ###headAndNeckEars,Large ears ;###headAndNeckEars,Low-set ears ###headAndNeckEyes,Prominent eyes ###headAndNeckNose,Wide nostrils ###headAndNeckMouth,Thick lips ;###headAndNeckMouth,Gingival hyperplasia ;###headAndNeckMouth,Large mouth ###chestBreasts,Breast hyperplasia (female) ;###chestBreasts,Prominent nipples ###abdomenExternalFeatures,Abdominal distention ###abdomenLiver,Cholestasis ;###abdomenLiver,Hepatic fibrosis ###abdomenPancreas,Islets of Langerhans hyperplasia ###genitourinaryExternalGenitaliaMale,Large penis ###genitourinaryExternalGenitaliaFemale,Large clitoris ###genitourinaryInternalGenitaliaMale,Leydig cell hyperplasia ###genitourinaryInternalGenitaliaFemale,Cystic ovaries ###skeletal,Delayed bone age ###skeletalHands,Large hands ###skeletalFeet,Large feet ###skinNailsHairSkin,Acanthosis nigricans ;###skinNailsHairSkin,Pachyderma ;###skinNailsHairSkin,Hyperkeratosis ###skinNailsHairNails,Dysplastic nails ###skinNailsHairHair,Hypertrichosis (body, face) ###muscleSoftTissue,Marked lack of adipose tissue ;###muscleSoftTissue,Muscle wasting ###endocrineFeatures,Hyperinsulinemia ;###endocrineFeatures,Precocious puberty ###immunology,Frequent infections ;###immunology,Decreased lymphatic tissue (tonsil, thymus, mesenteric nodes, Peyer patches) ###neoplasia,Juvenile ovarian granulosa cell tumor ###laboratoryAbnormalities,Elevated plasma insulin ;###laboratoryAbnormalities,Absent anti-insulin receptor antibodies ;###laboratoryAbnormalities,Postprandial hyperglycemia ;###laboratoryAbnormalities,Fasting hypoglycemia ###miscellaneous,Death often in early infancy ###molecularBasis,Caused by mutation in the insulin receptor gene (INSR, ) 3.$$$mimNumber,262190###prefix,####preferredTitle,PINEAL HYPERPLASIA, INSULIN-RESISTANT DIABETES MELLITUS, AND SOMATIC ABNORMALITIES###inheritance,Autosomal recessive ###growthHeight,Short stature ###growthWeight,Weight less than 5th percentile ###growthOther,Small for gestational age ###headAndNeckFace,Coarse facies ;###headAndNeckFace,Prognathism ###headAndNeckMouth,Large, fissured tongue ;###headAndNeckMouth,Gingival hypoplasia ;###headAndNeckMouth,High-arched palate ###headAndNeckTeeth,Dental dysplasia ;###headAndNeckTeeth,Premature eruption of teeth ###genitourinaryExternalGenitaliaMale,Large penis ###genitourinaryExternalGenitaliaFemale,Clitoromegaly ###skinNailsHairSkin,Acanthosis nigricans ;###skinNailsHairSkin,Dry skin ;###skinNailsHairSkin,Lichenified skin ###skinNailsHairNails,Onychauxis ###skinNailsHairHair,Hypertrichosis ###neurologicCentralNervousSystem,Pineal hypertrophy ;###neurologicCentralNervousSystem,Developmental delay ###endocrineFeatures,Insulin resistant diabetes mellitus ;###endocrineFeatures,Diabetic ketoacidosis ;###endocrineFeatures,Altered melatonin secretion ;###endocrineFeatures,Precocious puberty ###laboratoryAbnormalities,Postprandial hyperglycemia (early in disease course) ;###laboratoryAbnormalities,Fasting hypoglycemia (early in disease course) ;###laboratoryAbnormalities,Hyperinsulinemia ###miscellaneous,Onset of acanthosis nigricans correlates with onset of diabetes ;###miscellaneous,Survival to 5-15 years of age ;###miscellaneous,Allelic to leprechaunism ()###molecularBasis,Caused by mutation in the insulin receptor gene (INSR, )",https://www.omim.org/entry/610549;https://www.omim.org/entry/609968;https://www.omim.org/entry/246200;https://www.omim.org/entry/262190,.,Autosomal dominant;Autosomal recessive,Het,19,7117407,C,T,.,.,PASS,0/1:60:104,57.69,"T$T$,$,$tTTt,tttt..,T,,,Ttttt.,TT.t,t,.,,T,tt.T,t,t,.,tTtt,,TTtttT..TT,t.ttt,t,t,,,,,t,tttttttt",missense_variant;missense_variant,INSR,3643,.,NM_001079817.1(INSR):c.3773G>A(p.Arg1258His);NM_000208.2(INSR):c.3809G>A(p.Arg1270His),NM_000208.2,exon21(21);exon22(22),P+=>P+;P+=>P+,.,.,0,0,6.529e-05,0.0005,9.694e-05,0.0006,0,5,0.00058,0,7,0.000058,0.00409836065574,2/488,http://exac.broadinstitute.org/variant/19-7117407-C-T,5.21,50.2,12,0.19,http://exac.broadinstitute.org/gene/ENSG00000171105,0.49574,.,0.01,D,0.047,B,0.009,B,0.363,N,0.949,D,-0.923,15.21,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,COSM1003129,1(endometrium),.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,"activation of MAPK activity (GO:0000187)|activation of protein kinase activity (GO:0032147)|activation of protein kinase B activity (GO:0032148)|carbohydrate metabolic process (GO:0005975)|cellular response to growth factor stimulus (GO:0071363)|cellular response to insulin stimulus (GO:0032869)|epidermis development (GO:0008544)|exocrine pancreas development (GO:0031017)|G-protein coupled receptor signaling pathway (GO:0007186)|glucose homeostasis (GO:0042593)|heart morphogenesis (GO:0003007)|insulin receptor signaling pathway (GO:0008286)|male sex determination (GO:0030238)|peptidyl-tyrosine autophosphorylation (GO:0038083)|peptidyl-tyrosine phosphorylation (GO:0018108)|positive regulation of cell migration (GO:0030335)|positive regulation of cell proliferation (GO:0008284)|positive regulation of developmental growth (GO:0048639)|positive regulation of DNA replication (GO:0045740)|positive regulation of glucose import (GO:0046326)|positive regulation of glycogen biosynthetic process (GO:0045725)|positive regulation of glycolytic process (GO:0045821)|positive regulation of MAPK cascade (GO:0043410)|positive regulation of mitosis (GO:0045840)|positive regulation of nitric oxide biosynthetic process (GO:0045429)|positive regulation of protein kinase B signaling (GO:0051897)|positive regulation of protein phosphorylation (GO:0001934)|positive regulation of respiratory burst (GO:0060267)|protein autophosphorylation (GO:0046777)|protein heterotetramerization (GO:0051290)|regulation of embryonic development (GO:0045995)|regulation of transcription, DNA-templated (GO:0006355)|signal transduction by phosphorylation (GO:0023014)|transformation of host cell by virus (GO:0019087)",caveola (GO:0005901)|endosome membrane (GO:0010008)|extracellular vesicular exosome (GO:0070062)|insulin receptor complex (GO:0005899)|integral component of plasma membrane (GO:0005887)|membrane (GO:0016020)|plasma membrane (GO:0005886)|receptor complex (GO:0043235),ATP binding (GO:0005524)|GTP binding (GO:0005525)|insulin binding (GO:0043559)|insulin receptor substrate binding (GO:0043560)|insulin-activated receptor activity (GO:0005009)|insulin-like growth factor I binding (GO:0031994)|insulin-like growth factor II binding (GO:0031995)|insulin-like growth factor receptor binding (GO:0005159)|phosphatidylinositol 3-kinase binding (GO:0043548)|protein tyrosine kinase activity (GO:0004713)|PTB domain binding (GO:0051425)|receptor signaling protein tyrosine kinase activity (GO:0004716),.,.,.,.,17,1,WAX032
